Montana
Prescription drug spending and prescribing in Montana, from Medicare Part D and Medicaid, with the life-science companies raising money there and state attorney general health-care antitrust cases. Compare every state.
In 2024, Medicare Part D plans paid $704M for prescriptions written in Montana, the 47th most of 52 states and territories, and 4.4% of its claims were opioids against 3.5% nationally.
- Medicare Part D, 2024: $704M
- Medicaid drugs, 2025: $356M
- Opioid share of claims: 4.4%
- Life-science raises, 2 years: $12M
How It Prescribes
Medicare Part D, 2024, by the prescriber's state| Share of Part D claims | Montana | United States | Difference |
|---|---|---|---|
| Opioids | 4.4% | 3.5% | +24% |
| Antibiotics | 3.8% | 4.4% | -14% |
| Antipsychotics | 2.0% | 1.7% | +14% |
Most Distinctive Drugs
Prescribed most out of line with the rest of the country: the drug's share of Montana's claims against its share nationally| Drug | Against national rate | Claims |
|---|---|---|
| Sodium Chloride/Nahco3/Kcl/Peg | 2.7× | 3,136 |
| Hydromorphone Hcl | 2.6× | 6,373 |
| Thyroid,pork | 2.4× | 3,577 |
| Tiotropium Br/Olodaterol Hcl | 2.4× | 5,096 |
| Fentanyl | 2.2× | 5,573 |
| Liraglutide | 2.2× | 2,384 |
| Methylphenidate Hcl | 2.2× | 6,134 |
| Mometasone/Formoterol | 2.0× | 2,241 |
| Prazosin Hcl | 1.9× | 7,684 |
| Cefuroxime Axetil | 1.9× | 6,746 |
Biggest Medicaid Drugs
What Montana's Medicaid program paid pharmacies, before rebates; see every drugLife-Science Fundraising
9 Form D raises by companies based in Montana in the last two years; the 10 largest. See all raises- Genesis New Ventures, LLC$4M · Biotech · Apr 29, 2025
- Elo Health, Inc.$3M · Other health care · Mar 26, 2025
- Iris Senior MD Investors LLC$3M · Other health care · Sep 30, 2025
- Smart Step Surgical LLC$665K · Other health care · Jul 2, 2025
- TogetherMade, PBC$450K · Other health care · Sep 15, 2026
- SWAN VALLEY MEDICAL, INC$100K · Other health care · Oct 24, 2025
- Solo-Dex, Inc.$35K · Biotech · Jul 22, 2025
- Alercell Inc$35K · Biotech · Oct 19, 2026
- DocSide, Inc.$33K · Other health care · Mar 19, 2025
State Attorney General Health-Care Cases
Antitrust cases Montana joined, newest first; see every case- Connecticut, et al. v. Sandoz, et al., Case No. 20-cv-3539 (E.D. Pa. June 10, 2020), MDL 2724 (E.D. Pa.)2020 · Pending
- Connecticut et al. v. Teva Pharmaceuticals USA, Inc. et al., No. 2:19-cv-02407, (E.D. Pa. filed in MDL 05/30/2019)2019 · Pending
- New York et al. v. Cephalon, No. 2:16-cv-04234 (E.D. Pa. Aug. 4, 2016)2016 · Settled
- Maryland v. SmithKline Beecham Corp., No. 2:06-cv-01298-JP (E.D.Pa Mar. 27, 2006)2006 · Settled
- Maryland et al. v. Perrigo Company, No. 1:04CV01398 (D.D.C. Aug. 17, 2004)2004 · Settled
- Texas et al. v. Organon (Remeron), No. 04-5126 (D.N.J. 2004)2004 · Settled
- In re Cardizem CD Antitrust Litigation 99-MD-1278 (E.D. Mich. Jan. 29, 2003), 332 F.3d 896 (6th Cir. 2003)2003 · Settled
- Ohio, et al, v. Bristol-Myers Squibb Co., et al.(D.D.C. 2002); see also In re Buspirone Antitrust Litigation,Case No. 01 CV 11401, MDL…2002 · Settled
- In re: Buspirone Antitrust Litigation,Case No. 01 CV 11401, MDL 1410, MDL 1413 (S .D.N.Y.) (see also Ohio v. Bristol Myers Squibb2001 · Settled
- In re DDAVP Antitrust LitigationConsent decree
Other States
Alabama · Alaska · Arizona · Arkansas · California · Colorado · Connecticut · Delaware · District of Columbia · Florida · Georgia · Hawaii · Idaho · Illinois · Indiana · Iowa · Kansas · Kentucky · Louisiana · Maine · Maryland · Massachusetts · Michigan · Minnesota · Mississippi · Missouri · Nebraska · Nevada · New Hampshire · New Jersey · New Mexico · New York · North Carolina · North Dakota · Ohio · Oklahoma · Oregon · Pennsylvania · Puerto Rico · Rhode Island · South Carolina · South Dakota · Tennessee · Texas · Utah · Vermont · Virginia · Washington · West Virginia · Wisconsin · Wyoming
Part D is by the prescriber's state, Medicaid by the paying state program, and Form D by the issuer's stated address. Amounts are before manufacturer rebates. Refreshed weekly. CMS Medicare Part D Prescribers by Geography; CMS State Drug Utilization Data; SEC Form D; NAAG